OptimizeRx Corp., a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, announced the appointment of Sarah Bast as Chief Marketing Officer. Bast brings more than two decades of pharmaceutical marketing experience to the leadership team, including deep expertise in point of care (POC) media strategy, analytics, and optimization across leading healthcare marketing organizations.
Most recently, Bast served as Executive Vice President, Investment Marketplace at Publicis Health Media, where she established partnerships and solution sets to support major pharmaceutical brands and helped establish specialized capabilities spanning POC media, electronic health records (EHRs), and telehealth. Throughout her career, she has guided marketing strategy for leading life sciences companies including Lilly, Bayer, Johnson & Johnson, and AstraZeneca, helping clients navigate an increasingly complex healthcare engagement landscape.
Bast joins OptimizeRx at a time of continued innovation and growth as the Company expands its portfolio of technology and POC solutions designed to simplify healthcare marketing and enable more meaningful engagement between life sciences brands, healthcare providers, and patients at critical moments of care.
Also Read: PropellerAds Upgrades NIKO AI Agent Into a Full Campaign Co-Pilot
As Chief Marketing Officer, Bast will lead OptimizeRx’s marketing strategy, brand positioning and go-to-market initiatives, strengthening the Company’s relationships with healthcare marketing agencies and in-house life sciences marketing teams, and supporting continued product innovation and commercial growth.
“OptimizeRx is one of the foundational partners in the point of care space, with a proven track record of enabling pharma brands to engage healthcare providers at the moments that matter most, and I’m excited to help shape what’s next,” said Bast. “As our industry evolves, there are new opportunities to make healthcare engagement more timely, relevant, and effective, and I look forward to working with the team to build on that momentum and deliver even greater value to brands.”
“Sarah’s decision to join OptimizeRx speaks to both the strength of the business we’ve built and the tremendous opportunity ahead,” said Steve Silvestro, Chief Executive Officer, OptimizeRx. “She has spent her career helping life sciences brands solve complex marketing challenges and understands firsthand how healthcare marketers can reach providers more effectively. As OptimizeRx enters its next phase of growth, her strategic vision and deep understanding of the market will help us strengthen our customer relationships and accelerate the development of solutions that improve healthcare engagement.”
SOURCE: OptimizeRx